for trials without intervention Indoleamine 2,
Conditions
Interventions
This prospective cohort study enrolled 305 consecutive patients in whom CAD was suspected,
and they all underwent coronary angiogram during January 2017 to June 2019.
Diagnostic
the patients who undergoing coronary angiogram
Sponsors
The Research Division Faculty of Medicine Siriraj Hospital, Mahidol University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Age > 18 years. 2. Willing to participate and able to understand, read and sign the informed consent document. 3. The patients in whom CAD was suspected, and they all underwent coronary angiogram. 4. Baseline laboratory test were obtained.
Exclusion criteria
Exclusion criteria: 1. Patients have no blood collected at enrollment 2. Patients with rheumatoid arthritis 3. Patients with allergic asthma 4. Patients with cancer 5. Patients with gingival fibroblasts 6. Patients with neuropathology of Alzheimer’s disease 7. Patients with transplantation 8. Patients with inflammatory bowel disease 9. Patients with Infectious disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| IDO activity correlated with coronary artery disease severity one year IDO activity between patients with and without CAD | — |
Secondary
| Measure | Time frame |
|---|---|
| IDO activity predicted Clinical endpoints at 1-year one year 1-year MACE or 1-year mortality based on biomarkers | — |
Countries
Thailand
Contacts
Public ContactNattawut Wongpraparut
Faculty of Medicine Siriraj Hospital, Mahidol University
Outcome results
None listed